We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina (MOH) Down 6.1% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
It has been about a month since the last earnings report for Molina (MOH - Free Report) . Shares have lost about 6.1% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Molina due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
MOH Q3 Earnings Beat on Cost Discipline Despite Higher MCR
Molina Healthcare reported third-quarter 2026 adjusted earnings per share (EPS) of 89 cents, which beat the Zacks Consensus Estimate by 23.6%. The bottom line declined 51.6% from the year-ago quarter's level.
Revenues amounted to $11.08 billion, which decreased 3.4% year over year. The top line surpassed the consensus mark by 1.4%.
Third-quarter earnings benefited from operating cost discipline and rate updates. However, declining membership, lower premium revenues and elevated medical costs weighed on performance.
MOH's Q3 Premium Revenue Trends
Premium revenues of $10.46 billion declined 3.5% year over year. The decrease reflected lower Medicaid and Marketplace membership, partially offset by rate updates.
Investment income declined 5.6% year over year to $102 million. Premium tax revenues decreased 1.2% to $500 million, while other revenues increased 4.5% to $23 million.
Medicaid premium revenues increased 2.3% year over year to $8.2 billion. Medicare premium revenues rose marginally to $1.62 billion from $1.61 billion in the prior-year quarter.
Marketplace premium revenues declined 46.4% year over year to $642 million, reflecting a significant contraction in the segment's revenue base.
Molina Healthcare's Membership Update
As of Sept. 30, 2026, total membership decreased 13.6% year over year to approximately 4.86 million. The company witnessed membership declines across all segments, with Marketplace experiencing the steepest contraction.
Medicaid membership declined 5.8% year over year to 4.37 million, while Medicare membership decreased 16.5% to 222,000.
Marketplace membership plunged 62.6% year over year to 267,000. Other membership fell to approximately 1,000 from 10,000 a year ago. The broad-based membership decline continued to pressure the insurer's premium revenue generation.
MOH's Q3 Medical Cost Performance
The consolidated medical care ratio (MCR), which represents medical costs as a percentage of premium revenues, deteriorated 30 basis points year over year to 92.9%. The higher ratio contributed to weaker earnings despite lower absolute medical care costs.
The Medicaid MCR increased to 93% from 92% a year ago, reflecting rate updates and stable medical cost trends.
The Medicare MCR improved to 93% from 93.6% in the prior-year period. The Marketplace MCR also improved significantly to 92.5% from 95.6%, reflecting normal seasonality and management's expectations.
Consolidated medical margin declined 7.4% year over year to $738 million. Medicaid medical margin fell to $577 million from $639 million, while Medicare medical margin improved to $113 million from $103 million.
Molina Healthcare's Expense and Profitability Update
Total operating expenses decreased 3.2% year over year to $10.98 billion, primarily reflecting lower medical care costs and general and administrative expenses.
Medical care costs declined 3.2% to $9.72 billion, while general and administrative expenses decreased 2.6% to $710 million. The adjusted G&A ratio remained unchanged year over year at 6.3%, reflecting continued operating discipline.
Interest expense increased 8.2% to $53 million, adding pressure to profitability.
Adjusted net income decreased 52.6% year over year to $46 million.
MOH's Q3 Financial Position
Molina Healthcare exited the third quarter with cash and cash equivalents of $4.48 billion, up from $4.25 billion at 2025-end. Total assets increased to $15.65 billion from $15.56 billion.
Long-term debt totaled $3.77 billion, remaining nearly unchanged from the 2025-end level. Total stockholders' equity increased to $4.16 billion from $4.07 billion.
Net cash provided by operating activities totaled $629 million in the first nine months of 2026, compared with net cash used in operating activities of $237 million in the year-ago period.
The improvement primarily reflected lower government receivable and payable settlements. Cash and investments at the parent company increased to $608 million from $223 million at 2025-end.
Molina Healthcare's 2026 Guidance
Management reaffirmed its full-year 2026 premium revenue guidance of approximately $42 billion and adjusted earnings guidance of at least $5.25 per share.
The company expects full-year GAAP earnings of at least $2.38 per share. Its adjusted net income guidance stands at $270 million, while GAAP net income is projected at $122 million.
Management highlighted signs of stabilizing medical cost trends and stronger rate updates for 2027, which could support an improvement in Medicaid margins.
How Have Estimates Been Moving Since Then?
It turns out, fresh estimates have trended downward during the past month.
The consensus estimate has shifted -24.17% due to these changes.
VGM Scores
At this time, Molina has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Molina has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Image: Bigstock
Molina (MOH) Down 6.1% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Molina (MOH - Free Report) . Shares have lost about 6.1% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Molina due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
MOH Q3 Earnings Beat on Cost Discipline Despite Higher MCR
Molina Healthcare reported third-quarter 2026 adjusted earnings per share (EPS) of 89 cents, which beat the Zacks Consensus Estimate by 23.6%. The bottom line declined 51.6% from the year-ago quarter's level.
Revenues amounted to $11.08 billion, which decreased 3.4% year over year. The top line surpassed the consensus mark by 1.4%.
Third-quarter earnings benefited from operating cost discipline and rate updates. However, declining membership, lower premium revenues and elevated medical costs weighed on performance.
MOH's Q3 Premium Revenue Trends
Premium revenues of $10.46 billion declined 3.5% year over year. The decrease reflected lower Medicaid and Marketplace membership, partially offset by rate updates.
Investment income declined 5.6% year over year to $102 million. Premium tax revenues decreased 1.2% to $500 million, while other revenues increased 4.5% to $23 million.
Medicaid premium revenues increased 2.3% year over year to $8.2 billion. Medicare premium revenues rose marginally to $1.62 billion from $1.61 billion in the prior-year quarter.
Marketplace premium revenues declined 46.4% year over year to $642 million, reflecting a significant contraction in the segment's revenue base.
Molina Healthcare's Membership Update
As of Sept. 30, 2026, total membership decreased 13.6% year over year to approximately 4.86 million. The company witnessed membership declines across all segments, with Marketplace experiencing the steepest contraction.
Medicaid membership declined 5.8% year over year to 4.37 million, while Medicare membership decreased 16.5% to 222,000.
Marketplace membership plunged 62.6% year over year to 267,000. Other membership fell to approximately 1,000 from 10,000 a year ago. The broad-based membership decline continued to pressure the insurer's premium revenue generation.
MOH's Q3 Medical Cost Performance
The consolidated medical care ratio (MCR), which represents medical costs as a percentage of premium revenues, deteriorated 30 basis points year over year to 92.9%. The higher ratio contributed to weaker earnings despite lower absolute medical care costs.
The Medicaid MCR increased to 93% from 92% a year ago, reflecting rate updates and stable medical cost trends.
The Medicare MCR improved to 93% from 93.6% in the prior-year period. The Marketplace MCR also improved significantly to 92.5% from 95.6%, reflecting normal seasonality and management's expectations.
Consolidated medical margin declined 7.4% year over year to $738 million. Medicaid medical margin fell to $577 million from $639 million, while Medicare medical margin improved to $113 million from $103 million.
Molina Healthcare's Expense and Profitability Update
Total operating expenses decreased 3.2% year over year to $10.98 billion, primarily reflecting lower medical care costs and general and administrative expenses.
Medical care costs declined 3.2% to $9.72 billion, while general and administrative expenses decreased 2.6% to $710 million. The adjusted G&A ratio remained unchanged year over year at 6.3%, reflecting continued operating discipline.
Interest expense increased 8.2% to $53 million, adding pressure to profitability.
Adjusted net income decreased 52.6% year over year to $46 million.
MOH's Q3 Financial Position
Molina Healthcare exited the third quarter with cash and cash equivalents of $4.48 billion, up from $4.25 billion at 2025-end. Total assets increased to $15.65 billion from $15.56 billion.
Long-term debt totaled $3.77 billion, remaining nearly unchanged from the 2025-end level. Total stockholders' equity increased to $4.16 billion from $4.07 billion.
Net cash provided by operating activities totaled $629 million in the first nine months of 2026, compared with net cash used in operating activities of $237 million in the year-ago period.
The improvement primarily reflected lower government receivable and payable settlements. Cash and investments at the parent company increased to $608 million from $223 million at 2025-end.
Molina Healthcare's 2026 Guidance
Management reaffirmed its full-year 2026 premium revenue guidance of approximately $42 billion and adjusted earnings guidance of at least $5.25 per share.
The company expects full-year GAAP earnings of at least $2.38 per share. Its adjusted net income guidance stands at $270 million, while GAAP net income is projected at $122 million.
Management highlighted signs of stabilizing medical cost trends and stronger rate updates for 2027, which could support an improvement in Medicaid margins.
How Have Estimates Been Moving Since Then?
It turns out, fresh estimates have trended downward during the past month.
The consensus estimate has shifted -24.17% due to these changes.
VGM Scores
At this time, Molina has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Molina has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.